Market Cap (In ILA)
38.9 Million
Revenue (In ILA)
22.77 Million
Net Income (In ILA)
553 Thousand
Avg. Volume
3843.00
- Currency
- ILA
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 190.0-355.0
- PE
- -
- EPS
- -
- Beta Value
- -0.284
- ISIN
- IL0011010217
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Yossi Bar-On CPA
- Employee Count
- -
- Website
- https://www.endymed.com
- Ipo Date
- 2007-07-19
- Details
- Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey.
More Stocks
-
KZG
-
083790CrystalGenomics, Inc.
083790
-
6605
-
1423
-
FLNGFLEX LNG Ltd.
FLNG
-
058470LEENO Industrial Inc.
058470
-
CANDLE-BCandles Scandinavia AB (publ)
CANDLE-B
-
ZAPZaptec AS
ZAP